Heron Therapeutics, Inc.

Símbolo: HRTX

NASDAQ

2.55

USD

Preço de mercado atual

  • -3.4755

    Rácio P/E

  • 0.0265

    Rácio PEG

  • 383.34M

    Capitalização da MRK

  • 0.00%

    Rendimento DIV

Heron Therapeutics, Inc. Estrutura de gestão

Informação de gestão

Nome da empresaTítulo
Ms. Ira DuarteExecutive Vice President & Chief Financial Officer
Jeff CohnExecutive Director, Assistant General Counsel & Assistant Secretary
Mr. Ryan CraigVice President of Marketing
Mr. Sean T. RistineSenior Vice President of Human Resources
Mr. Robert SullivanSenior Vice President of Oncology Care Franchise & Commercial Operations
Dr. William P. Forbes Pharm. D., Pharm.D.Executive Vice President & Chief Development Officer
Mr. Craig Alexander CollardChief Executive Officer & Director